High drug prices have created barriers to accessing medications, and Gerard Anderson, PhD, of Johns Hopkins Bloomberg School of Public Health, suggests that the pricing algorithms need to change in order to improve this dilemma.
High drug prices have created barriers to accessing medications, and Gerard Anderson, PhD, of Johns Hopkins Bloomberg School of Public Health, suggests that the pricing algorithms need to change in order to improve this dilemma.
Transcript (slightly modified)
What do you view as the biggest barrier to access to medications?
I’m really focused on the high cost drugs. So, for that it’s really the price and we basically have a system where only about 20% of the people can afford these very expensive drugs because a program like Medicare puts very high cost-sharing on it. Medicaid doesn’t typically cover them, the Bureau of Prisons, the Indian Health Services, don’t cover those things because they’re so expensive. So, I think the major problem that I am seeing right now for many people is the very high cost drugs. For a lot of people, they just don’t have any money at all and so even having a very little cost sharing is devastating. A program like the Patient Access Network is critical for them but I think what new situation that is happening is that the very expensive drugs have become the problem.
How can access be improved?
Essentially for the very high cost drugs, we need to figure out a way to get price times quantity down, so that the price is way down and the quantity is way up. Right now, the pricing algorithms that most of the drug companies have assume that very few people will buy the drug at a very high price, and from a public health point of view, we want a lower price but a much higher quantity so that the drug companies still have the same revenue, but we essentially get as many people as possible covered.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More